Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ritch

Showing results (371-380 of 383) with videos related to

Pageof 39
Sort By:
Human Molecular Genetics|April 10, 1999
Analysis of myocilin mutations in 1703 glaucoma patients from five different populationsJ H Fingert, E Héon, J M Liebmann, et al.
Prostate Cancer and Prostatic Diseases|September 27, 2024
Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS scoreHelen Y Hougen, Isildinha M Reis, Sunwoo Han, et al.
The Journal of Urology|December 28, 2020
Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted BiopsySanoj Punnen, Radka Stoyanova, Deukwoo Kwon, et al.
Ophthalmology|October 1, 1998
Novel trabecular meshwork inducible glucocorticoid response mutation in an eight-generation juvenile-onset primary open-angle glaucoma pedigreeJ E Richards, R Ritch, P R Lichter, et al.
Academic Radiology|December 18, 2024
HRS Improves Active Surveillance for Prostate Cancer by Timely Identification of ProgressionIsabella M Kimbel, Veronica Wallaengen, Evangelia I Zacharaki, et al.
BJU International|May 6, 2026
Multiparametric MRI in prostate cancer active surveillance: results from the Miami Active Surveillance Trial (MAST) trialSeyed Hossein Hosseini Sharifi, Adam Williams, Jonathan T Ryan, et al.
Cancers|March 14, 2026
mpMRI-Based Risk Estimation to Optimize Prostate Cancer Patient Selection for Active SurveillanceVeronica Wallaengen, Evangelia I Zacharaki, Mohammad Alhusseini, et al.
BJU International|February 27, 2026
Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST)Ankur Malpani, Jonathan T Ryan, Hui Yu, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 13, 2006
A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucomaPaul P Lee, John G Walt, John J Doyle, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 20, 2026
MRI-based patient selection for active surveillance in prostate cancer using U-Found: a generalized deep learning modelNoah C Lowry, Adrian L Breto, Veronica Wallaengen, et al.
Pageof 39

Showing results (371-380 of 383) with videos related to

Sort By:
Pageof 39
Human Molecular Genetics|April 10, 1999
Analysis of myocilin mutations in 1703 glaucoma patients from five different populationsJ H Fingert, E Héon, J M Liebmann, et al.
Prostate Cancer and Prostatic Diseases|September 27, 2024
Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS scoreHelen Y Hougen, Isildinha M Reis, Sunwoo Han, et al.
The Journal of Urology|December 28, 2020
Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted BiopsySanoj Punnen, Radka Stoyanova, Deukwoo Kwon, et al.
Ophthalmology|October 1, 1998
Novel trabecular meshwork inducible glucocorticoid response mutation in an eight-generation juvenile-onset primary open-angle glaucoma pedigreeJ E Richards, R Ritch, P R Lichter, et al.
Academic Radiology|December 18, 2024
HRS Improves Active Surveillance for Prostate Cancer by Timely Identification of ProgressionIsabella M Kimbel, Veronica Wallaengen, Evangelia I Zacharaki, et al.
BJU International|May 6, 2026
Multiparametric MRI in prostate cancer active surveillance: results from the Miami Active Surveillance Trial (MAST) trialSeyed Hossein Hosseini Sharifi, Adam Williams, Jonathan T Ryan, et al.
Cancers|March 14, 2026
mpMRI-Based Risk Estimation to Optimize Prostate Cancer Patient Selection for Active SurveillanceVeronica Wallaengen, Evangelia I Zacharaki, Mohammad Alhusseini, et al.
BJU International|February 27, 2026
Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST)Ankur Malpani, Jonathan T Ryan, Hui Yu, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 13, 2006
A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucomaPaul P Lee, John G Walt, John J Doyle, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 20, 2026
MRI-based patient selection for active surveillance in prostate cancer using U-Found: a generalized deep learning modelNoah C Lowry, Adrian L Breto, Veronica Wallaengen, et al.
Pageof 39